Triple or Drug Combination for the Medical Management of Inoperable Malignant Bowel Obstruction: Does It Make a Difference?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Triple or Drug Combination for the Medical Management of Inoperable Malignant Bowel Obstruction: Does It Make a Difference?

Published:2024-06 Issue:6 Volume:67 Page:e917-e918
ISSN:0885-3924
Container-title:Journal of Pain and Symptom Management
language:en
Short-container-title:Journal of Pain and Symptom Management

Author:

Mercadante Sebastiano

Publisher

Elsevier BV

Reference6 articles.

1. Palliative management of inoperable malignant bowel obstruction: prospective, open label, phase 2 study at an NCI Comprehensive Cancer Center;Walter;J Pain Symptom Manage,2024

2. Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update;Davis;Support Care Cancer,2021

3. Palliative medical management of inoperable malignant bowel obstruction with “triple therapy”: dexamethasone, octreotide, and metoclopramide;Wey;Am J Hosp Palliat Care,2021

4. Aggressive pharmacological treatment for reversing malignant bowel obstruction;Mercadante;J Pain Symptom Manage,2004

5. Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients;Mercadante;J Pain Symptom Manage,1992

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP